Ronald Dalman named associate dean for market development

In the new role of associate dean for market development, Ronald Dalman will partner with Stanford Health Care business development leadership and others to fulfill regional goals of the integrated strategic plan.

Ronald Dalman

Ronald Dalman, MD, the Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery and chief of vascular surgery, has been appointed associate dean for market development at the School of Medicine.

In this new role, Dalman will serve as faculty partner for Stanford Health Care market and business development leadership. He will also work closely with clinical chairs, chiefs and staff to identify and optimize network and affiliation agreements across the region to achieve established goals of the integrated strategic plan.

Dalman joined the medical school faculty in 1992. Prior to assuming leadership of the Division of Vascular Surgery in 2005, he served as vascular section chief at the Veterans Affairs Palo Alto Health Care System. In addition to his clinical roles, Dalman serves on the steering committee of the Stanford Cardiovascular Research Institute

Dalman’s research laboratory studies the pathophysiology of abdominal aortic aneurysm disease and is actively engaged in identifying and validating new treatment measures for AAA. He has received 19 years of continuous National Institutes of Health funding as principal investigator or co-principal investigator on AAA-related clinical and translational research studies.

Dalman is the current vice president of the Society for Vascular Surgery, the world’s largest and oldest professional organization dedicated exclusively to improving vascular health. He will become president-elect of the society in 2019.

Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.

Leading In Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.